Is the UK still an attractive option for PE?

This week’s blog comes from Paddy Moser, partner in UKI Transaction Advisory Private Equity.  We recently highlighted the continuing attraction of UK assets for corporate buyers – but what about private equity? In this week’s blog, I’ll explore the tension between opportunity and uncertainty for PE buyers in the UK and how it’s affecting deal … More Is the UK still an attractive option for PE?

Why is ‘take private’ such a hot topic?

This week’s blog comes from Fredrik Bürger, who leads EY’s Private Equity Value Creation service offering. Public-to-private transactions (PTP) are well and truly back on the private equity agenda. While by no means reaching the peaks of 2006-7, ‘take-private’ deals have picked up in the last two years and look set to accelerate in 2019. … More Why is ‘take private’ such a hot topic?

What’s behind PE’s latest health-kick?

This week’s blog comes from Matt Bartell, EY’s UKI Transaction Advisory Life Sciences Leader and Paddy Moser, co-leader of UKI Transaction Advisory Private Equity.  There’s no doubt that health is one of the biggest stories in private equity right now. In the second quarter, the healthcare sector accounted for almost a quarter of global PE … More What’s behind PE’s latest health-kick?